{"id":"methylphenobarbital","rwe":[{"pmid":"28054643","year":"2017","title":"Network-Based Approach to Identify Potential Targets and Drugs that Promote Neuroprotection and Neurorepair in Acute Ischemic Stroke.","finding":"","journal":"Scientific reports","studyType":"Clinical Study"},{"pmid":"19630487","year":"2009","title":"Psycho-pharmacotherapy for anxiety and obsessive-compulsive disorder: the issue of prolonged barbiturate retention.","finding":"","journal":"Current medical research and opinion","studyType":"Clinical Study"},{"pmid":"19218807","year":"2009","title":"Fetal malformations associated with the use of methylphenobarbital and carbamazepine during pregnancy. Two case reports and review of the literature.","finding":"","journal":"Fetal diagnosis and therapy","studyType":"Clinical Study"},{"pmid":"19190392","year":"2009","title":"The influence of sulfur substituents on the molecular geometry and packing of thio derivatives of N-methylphenobarbital.","finding":"","journal":"Acta crystallographica. Section C, Crystal structure communications","studyType":"Clinical Study"},{"pmid":"17225740","year":"2006","title":"[Intoxication due to replacement of the precursor methylphenobarbital by phenobarbital].","finding":"","journal":"Nederlands tijdschrift voor geneeskunde","studyType":"Clinical Study"}],"tags":[{"label":"methylphenobarbital","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"GABA-A receptor alpha-1/beta-3/gamma-2","category":"target"},{"label":"GABRA1","category":"gene"},{"label":"GABRB3","category":"gene"},{"label":"GABRG2","category":"gene"},{"label":"N03AA01","category":"atc"},{"label":"Active","category":"status"},{"label":"Anxiety","category":"indication"},{"label":"Apprehension","category":"indication"},{"label":"Epilepsy","category":"indication"},{"label":"Tension","category":"indication"},{"label":"Tonic-clonic epilepsy","category":"indication"},{"label":"Anticonvulsants","category":"pharmacology"},{"label":"Central Nervous System Agents","category":"pharmacology"},{"label":"Central Nervous System Depressants","category":"pharmacology"},{"label":"GABA Agents","category":"pharmacology"},{"label":"GABA Modulators","category":"pharmacology"},{"label":"Hypnotics and Sedatives","category":"pharmacology"},{"label":"Neurotransmitter Agents","category":"pharmacology"}],"phase":"marketed","safety":{"drugInteractions":[{"url":"/drug/ciclosporin","drug":"ciclosporin","action":"Monitor closely","effect":"May interact with Cyclosporine, Mephobarbital","source":"DrugCentral","drugSlug":"ciclosporin"},{"url":"/drug/phenprocoumon","drug":"phenprocoumon","action":"Avoid combination","effect":"May interact with Mephobarbital, Phenprocoumon","source":"DrugCentral","drugSlug":"phenprocoumon"}],"contraindications":["Acute exacerbation of asthma","Alcoholism","Anemia","Chronic obstructive lung disease","Depressive disorder","Disease of liver","Hepatic coma","Hepatic encephalopathy","Hepatic failure","Hyperactive behavior","Hyperammonemia","Kidney disease","Neutropenic disorder","Porphyria","Pregnancy, function","Respiratory insufficiency","Sleep apnea","Sleep automatism","Substance abuse","Suicidal thoughts","Thrombocytopenic disorder"]},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=methylphenobarbital","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:58:00.391086+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:58:05.959481+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=methylphenobarbital","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:58:06.368085+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL45029/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:58:07.158778+00:00"}},"allNames":"metylfenemal","offLabel":[],"synonyms":["mephobarbital","mephobarbitone","methylphenobarbital","methylphenobarbitone","metylfenemal"],"timeline":[{"date":"1935-01-01","type":"positive","source":"DrugCentral","milestone":"YEAR INTRODUCED approval"}],"approvals":[{"date":"1935-01-01","orphan":false,"company":"","regulator":"YEAR INTRODUCED"}],"brandName":"Metylfenemal","ecosystem":[{"indication":"Anxiety","otherDrugs":[{"name":"alprazolam","slug":"alprazolam","company":"Pharmacia And Upjohn"},{"name":"chlordiazepoxide","slug":"chlordiazepoxide","company":"Valeant Pharm Intl"},{"name":"chlormezanone","slug":"chlormezanone","company":""},{"name":"clorazepate","slug":"clorazepate","company":"Recordati Rare"}],"globalPrevalence":301000000},{"indication":"Apprehension","otherDrugs":[],"globalPrevalence":null},{"indication":"Epilepsy","otherDrugs":[{"name":"amobarbital","slug":"amobarbital","company":""},{"name":"carbamazepine","slug":"carbamazepine","company":"Novartis"},{"name":"diazepam","slug":"diazepam","company":"Roche"},{"name":"felbamate","slug":"felbamate","company":"Meda Pharms"}],"globalPrevalence":50000000},{"indication":"Tension","otherDrugs":[],"globalPrevalence":1280000000},{"indication":"Tonic-clonic epilepsy","otherDrugs":[{"name":"carbamazepine","slug":"carbamazepine","company":"Novartis"},{"name":"ethotoin","slug":"ethotoin","company":"Recordati Rare"},{"name":"metharbital","slug":"metharbital","company":"Abbvie"},{"name":"phenytoin","slug":"phenytoin","company":"Parke Davis"}],"globalPrevalence":50000000}],"mechanism":{"target":"GABA-A receptor alpha-1/beta-3/gamma-2","targets":[{"gene":"GABRA1","source":"DrugCentral","target":"GABA-A receptor alpha-1/beta-3/gamma-2","protein":"Gamma-aminobutyric acid receptor subunit alpha-1"},{"gene":"GABRB3","source":"DrugCentral","target":"GABA-A receptor alpha-1/beta-3/gamma-2","protein":"Gamma-aminobutyric acid receptor subunit beta-3"},{"gene":"GABRG2","source":"DrugCentral","target":"GABA-A receptor alpha-1/beta-3/gamma-2","protein":"Gamma-aminobutyric acid receptor subunit gamma-2"}],"modality":"Small Molecule","drugClass":"methylphenobarbital","explanation":"","oneSentence":"","technicalDetail":"Methylphenobarbital acts as a positive allosteric modulator of the GABA-A receptor, enhancing the frequency of chloride channel opening and increasing the duration of GABAergic inhibition, which results in a decrease in neuronal excitability and a calming effect on the nervous system."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/1696","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=methylphenobarbital","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T12:40:04.791608","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:58:08.753375+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"primidone","drugSlug":"primidone","fdaApproval":"1954-03-08","genericCount":10,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"metharbital","drugSlug":"metharbital","fdaApproval":"","patentStatus":"Unknown","relationship":"same-class"}],"genericName":"methylphenobarbital","indications":{"approved":[{"name":"Anxiety","source":"DrugCentral","snomedId":48694002,"regulator":"FDA","usPrevalence":40000000,"globalPrevalence":301000000,"prevalenceMethod":"curated","prevalenceSource":"WHO, 2022"},{"name":"Apprehension","source":"DrugCentral","snomedId":49971008,"regulator":"FDA"},{"name":"Epilepsy","source":"DrugCentral","snomedId":84757009,"regulator":"FDA","usPrevalence":3400000,"globalPrevalence":50000000,"prevalenceMethod":"curated","prevalenceSource":"WHO, 2023"},{"name":"Tension","source":"DrugCentral","snomedId":53489000,"regulator":"FDA","usPrevalence":119900000,"globalPrevalence":1280000000,"prevalenceMethod":"curated","prevalenceSource":"WHO, 2023"},{"name":"Tonic-clonic epilepsy","source":"DrugCentral","snomedId":352818000,"regulator":"FDA","usPrevalence":3400000,"globalPrevalence":50000000,"prevalenceMethod":"curated","prevalenceSource":"WHO, 2023"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"primidone","brandName":"primidone","genericName":"primidone","approvalYear":"1954","relationship":"same-class"},{"drugId":"metharbital","brandName":"metharbital","genericName":"metharbital","approvalYear":"","relationship":"same-class"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NUI":"N0000146576","MMSL":"11888","NDDF":"001417","UNII":"5NC67NU76B","VUID":"4018245","CHEBI":"CHEBI:6758","VANDF":"4018245","INN_ID":"2901","RXNORM":"6758","UMLSCUI":"C0025382","chemblId":"CHEMBL45029","ChEMBL_ID":"CHEMBL399103","KEGG_DRUG":"D00700","DRUGBANK_ID":"DB00849","PUBCHEM_CID":"8271","SNOMEDCT_US":"387252006","MESH_DESCRIPTOR_UI":"D008618"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"pharmacokinetics":{"source":"DrugCentral","bioavailability":"73%"},"publicationCount":48,"therapeuticAreas":["Neuroscience"],"atcClassification":{"source":"DrugCentral","atcCode":"N03AA01","allCodes":["N03AA01"]},"biosimilarFilings":[],"recentPublications":[{"date":"2017 Jan 5","pmid":"28054643","title":"Network-Based Approach to Identify Potential Targets and Drugs that Promote Neuroprotection and Neurorepair in Acute Ischemic Stroke.","journal":"Scientific reports"},{"date":"2009 Sep","pmid":"19630487","title":"Psycho-pharmacotherapy for anxiety and obsessive-compulsive disorder: the issue of prolonged barbiturate retention.","journal":"Current medical research and opinion"},{"date":"2009","pmid":"19218807","title":"Fetal malformations associated with the use of methylphenobarbital and carbamazepine during pregnancy. Two case reports and review of the literature.","journal":"Fetal diagnosis and therapy"},{"date":"2009 Feb","pmid":"19190392","title":"The influence of sulfur substituents on the molecular geometry and packing of thio derivatives of N-methylphenobarbital.","journal":"Acta crystallographica. Section C, Crystal structure communications"},{"date":"2006 Apr 29","pmid":"17225740","title":"[Intoxication due to replacement of the precursor methylphenobarbital by phenobarbital].","journal":"Nederlands tijdschrift voor geneeskunde"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"OTHER","regulator":"YEAR INTRODUCED","status":"approved","approval_date":"1935-01-01T00:00:00.000Z","mah":"","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:58:08.753375+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":false,"score":1}}